J HYPERTENS 润色咨询

JOURNAL OF HYPERTENSION

出版年份:暂无数据 年文章数:3734 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:9.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2146941, encodeId=0eff2146941f8, content=返修两月后连着三天显示decision in process是咋回事?要被拒了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44cf5506636, createdName=ms2000000177740546, createdTime=Sat Jul 08 08:51:06 CST 2023, time=2023-07-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1067018, encodeId=cc66106e01811, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投稿约一个月后Under review,过两周Minor revision,一周后修回,过十天Under review,一天后Decision in process,再过一天Accept。投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Nov 04 19:37:08 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115182, encodeId=daed2115182bf, content=偏重的研究方向:脉压差;高血压<br>经验分享:停在required review completed好几天是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63bb2396905, createdName=12346673m56暂无昵称, createdTime=Sat Feb 18 00:24:42 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=525657, encodeId=ee9252565ee1, content=一审一个月拒稿,但表示可以修改后重投,7月29号投回去,现在是required reviewers completed 已经三天了,坐等结果!各位大神有过这样的经验没有,急求!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab876092, createdName=dongjun2935, createdTime=Mon Aug 08 16:16:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103971, encodeId=50ce21039e139, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:临床回顾性研究,两天拒稿,良心杂志啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cabd8369335, createdName=ms1000001052076493, createdTime=Fri Dec 02 17:42:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=538256, encodeId=7ff253825675, content=今早查with editor了,还有一个共同作者没有confirm copyright。分享下经验,大家投这个杂志不用先催着合作者confirm<span class="quote">around 2017-06-18 发表::<br>请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?</span>, beContent=around 2017-06-18 发表:: 请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Tue Jun 20 15:18:00 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207830, encodeId=08f0120e8302c, content=三个月了,还是显示under review,需要发邮件去问一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3475306406, createdName=14879d50m30暂无昵称, createdTime=Fri Apr 01 13:08:47 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214985, encodeId=fac9121498519, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:高血压<br>经验分享:昨天晚上投稿,今早一醒来拒稿了,这个速度我真的会谢,让我转投medicine,感觉都是套路,直接拒绝,栓Q, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Wed Apr 27 10:31:26 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093359, encodeId=05e41093359a6, content=什么样的题目能让审稿人眼前一亮?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093360, encodeId=5d7310933603d, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-07-08 ms2000000177740546 来自四川省

    返修两月后连着三天显示decision in process是咋回事?要被拒了嘛?

    5

    展开5条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2146941, encodeId=0eff2146941f8, content=返修两月后连着三天显示decision in process是咋回事?要被拒了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44cf5506636, createdName=ms2000000177740546, createdTime=Sat Jul 08 08:51:06 CST 2023, time=2023-07-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1067018, encodeId=cc66106e01811, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投稿约一个月后Under review,过两周Minor revision,一周后修回,过十天Under review,一天后Decision in process,再过一天Accept。投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Nov 04 19:37:08 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115182, encodeId=daed2115182bf, content=偏重的研究方向:脉压差;高血压<br>经验分享:停在required review completed好几天是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63bb2396905, createdName=12346673m56暂无昵称, createdTime=Sat Feb 18 00:24:42 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=525657, encodeId=ee9252565ee1, content=一审一个月拒稿,但表示可以修改后重投,7月29号投回去,现在是required reviewers completed 已经三天了,坐等结果!各位大神有过这样的经验没有,急求!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab876092, createdName=dongjun2935, createdTime=Mon Aug 08 16:16:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103971, encodeId=50ce21039e139, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:临床回顾性研究,两天拒稿,良心杂志啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cabd8369335, createdName=ms1000001052076493, createdTime=Fri Dec 02 17:42:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=538256, encodeId=7ff253825675, content=今早查with editor了,还有一个共同作者没有confirm copyright。分享下经验,大家投这个杂志不用先催着合作者confirm<span class="quote">around 2017-06-18 发表::<br>请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?</span>, beContent=around 2017-06-18 发表:: 请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Tue Jun 20 15:18:00 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207830, encodeId=08f0120e8302c, content=三个月了,还是显示under review,需要发邮件去问一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3475306406, createdName=14879d50m30暂无昵称, createdTime=Fri Apr 01 13:08:47 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214985, encodeId=fac9121498519, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:高血压<br>经验分享:昨天晚上投稿,今早一醒来拒稿了,这个速度我真的会谢,让我转投medicine,感觉都是套路,直接拒绝,栓Q, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Wed Apr 27 10:31:26 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093359, encodeId=05e41093359a6, content=什么样的题目能让审稿人眼前一亮?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093360, encodeId=5d7310933603d, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-11-04 ms4000001698136241

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:投稿约一个月后Under review,过两周Minor revision,一周后修回,过十天Under review,一天后Decision in process,再过一天Accept。投稿到接收2个月

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2146941, encodeId=0eff2146941f8, content=返修两月后连着三天显示decision in process是咋回事?要被拒了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44cf5506636, createdName=ms2000000177740546, createdTime=Sat Jul 08 08:51:06 CST 2023, time=2023-07-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1067018, encodeId=cc66106e01811, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投稿约一个月后Under review,过两周Minor revision,一周后修回,过十天Under review,一天后Decision in process,再过一天Accept。投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Nov 04 19:37:08 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115182, encodeId=daed2115182bf, content=偏重的研究方向:脉压差;高血压<br>经验分享:停在required review completed好几天是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63bb2396905, createdName=12346673m56暂无昵称, createdTime=Sat Feb 18 00:24:42 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=525657, encodeId=ee9252565ee1, content=一审一个月拒稿,但表示可以修改后重投,7月29号投回去,现在是required reviewers completed 已经三天了,坐等结果!各位大神有过这样的经验没有,急求!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab876092, createdName=dongjun2935, createdTime=Mon Aug 08 16:16:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103971, encodeId=50ce21039e139, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:临床回顾性研究,两天拒稿,良心杂志啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cabd8369335, createdName=ms1000001052076493, createdTime=Fri Dec 02 17:42:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=538256, encodeId=7ff253825675, content=今早查with editor了,还有一个共同作者没有confirm copyright。分享下经验,大家投这个杂志不用先催着合作者confirm<span class="quote">around 2017-06-18 发表::<br>请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?</span>, beContent=around 2017-06-18 发表:: 请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Tue Jun 20 15:18:00 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207830, encodeId=08f0120e8302c, content=三个月了,还是显示under review,需要发邮件去问一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3475306406, createdName=14879d50m30暂无昵称, createdTime=Fri Apr 01 13:08:47 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214985, encodeId=fac9121498519, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:高血压<br>经验分享:昨天晚上投稿,今早一醒来拒稿了,这个速度我真的会谢,让我转投medicine,感觉都是套路,直接拒绝,栓Q, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Wed Apr 27 10:31:26 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093359, encodeId=05e41093359a6, content=什么样的题目能让审稿人眼前一亮?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093360, encodeId=5d7310933603d, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-02-18 12346673m56暂无昵称 来自北京

    偏重的研究方向:脉压差;高血压
    经验分享:停在required review completed好几天是怎么回事

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2146941, encodeId=0eff2146941f8, content=返修两月后连着三天显示decision in process是咋回事?要被拒了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44cf5506636, createdName=ms2000000177740546, createdTime=Sat Jul 08 08:51:06 CST 2023, time=2023-07-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1067018, encodeId=cc66106e01811, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投稿约一个月后Under review,过两周Minor revision,一周后修回,过十天Under review,一天后Decision in process,再过一天Accept。投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Nov 04 19:37:08 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115182, encodeId=daed2115182bf, content=偏重的研究方向:脉压差;高血压<br>经验分享:停在required review completed好几天是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63bb2396905, createdName=12346673m56暂无昵称, createdTime=Sat Feb 18 00:24:42 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=525657, encodeId=ee9252565ee1, content=一审一个月拒稿,但表示可以修改后重投,7月29号投回去,现在是required reviewers completed 已经三天了,坐等结果!各位大神有过这样的经验没有,急求!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab876092, createdName=dongjun2935, createdTime=Mon Aug 08 16:16:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103971, encodeId=50ce21039e139, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:临床回顾性研究,两天拒稿,良心杂志啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cabd8369335, createdName=ms1000001052076493, createdTime=Fri Dec 02 17:42:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=538256, encodeId=7ff253825675, content=今早查with editor了,还有一个共同作者没有confirm copyright。分享下经验,大家投这个杂志不用先催着合作者confirm<span class="quote">around 2017-06-18 发表::<br>请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?</span>, beContent=around 2017-06-18 发表:: 请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Tue Jun 20 15:18:00 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207830, encodeId=08f0120e8302c, content=三个月了,还是显示under review,需要发邮件去问一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3475306406, createdName=14879d50m30暂无昵称, createdTime=Fri Apr 01 13:08:47 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214985, encodeId=fac9121498519, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:高血压<br>经验分享:昨天晚上投稿,今早一醒来拒稿了,这个速度我真的会谢,让我转投medicine,感觉都是套路,直接拒绝,栓Q, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Wed Apr 27 10:31:26 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093359, encodeId=05e41093359a6, content=什么样的题目能让审稿人眼前一亮?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093360, encodeId=5d7310933603d, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2016-08-08 dongjun2935

    一审一个月拒稿,但表示可以修改后重投,7月29号投回去,现在是required reviewers completed 已经三天了,坐等结果!各位大神有过这样的经验没有,急求!

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2146941, encodeId=0eff2146941f8, content=返修两月后连着三天显示decision in process是咋回事?要被拒了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44cf5506636, createdName=ms2000000177740546, createdTime=Sat Jul 08 08:51:06 CST 2023, time=2023-07-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1067018, encodeId=cc66106e01811, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投稿约一个月后Under review,过两周Minor revision,一周后修回,过十天Under review,一天后Decision in process,再过一天Accept。投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Nov 04 19:37:08 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115182, encodeId=daed2115182bf, content=偏重的研究方向:脉压差;高血压<br>经验分享:停在required review completed好几天是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63bb2396905, createdName=12346673m56暂无昵称, createdTime=Sat Feb 18 00:24:42 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=525657, encodeId=ee9252565ee1, content=一审一个月拒稿,但表示可以修改后重投,7月29号投回去,现在是required reviewers completed 已经三天了,坐等结果!各位大神有过这样的经验没有,急求!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab876092, createdName=dongjun2935, createdTime=Mon Aug 08 16:16:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103971, encodeId=50ce21039e139, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:临床回顾性研究,两天拒稿,良心杂志啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cabd8369335, createdName=ms1000001052076493, createdTime=Fri Dec 02 17:42:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=538256, encodeId=7ff253825675, content=今早查with editor了,还有一个共同作者没有confirm copyright。分享下经验,大家投这个杂志不用先催着合作者confirm<span class="quote">around 2017-06-18 发表::<br>请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?</span>, beContent=around 2017-06-18 发表:: 请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Tue Jun 20 15:18:00 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207830, encodeId=08f0120e8302c, content=三个月了,还是显示under review,需要发邮件去问一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3475306406, createdName=14879d50m30暂无昵称, createdTime=Fri Apr 01 13:08:47 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214985, encodeId=fac9121498519, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:高血压<br>经验分享:昨天晚上投稿,今早一醒来拒稿了,这个速度我真的会谢,让我转投medicine,感觉都是套路,直接拒绝,栓Q, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Wed Apr 27 10:31:26 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093359, encodeId=05e41093359a6, content=什么样的题目能让审稿人眼前一亮?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093360, encodeId=5d7310933603d, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-12-02 ms1000001052076493 来自广东省

    审稿速度:1.0 | 投稿命中率:5.0
    经验分享:临床回顾性研究,两天拒稿,良心杂志啊!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2146941, encodeId=0eff2146941f8, content=返修两月后连着三天显示decision in process是咋回事?要被拒了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44cf5506636, createdName=ms2000000177740546, createdTime=Sat Jul 08 08:51:06 CST 2023, time=2023-07-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1067018, encodeId=cc66106e01811, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投稿约一个月后Under review,过两周Minor revision,一周后修回,过十天Under review,一天后Decision in process,再过一天Accept。投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Nov 04 19:37:08 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115182, encodeId=daed2115182bf, content=偏重的研究方向:脉压差;高血压<br>经验分享:停在required review completed好几天是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63bb2396905, createdName=12346673m56暂无昵称, createdTime=Sat Feb 18 00:24:42 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=525657, encodeId=ee9252565ee1, content=一审一个月拒稿,但表示可以修改后重投,7月29号投回去,现在是required reviewers completed 已经三天了,坐等结果!各位大神有过这样的经验没有,急求!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab876092, createdName=dongjun2935, createdTime=Mon Aug 08 16:16:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103971, encodeId=50ce21039e139, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:临床回顾性研究,两天拒稿,良心杂志啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cabd8369335, createdName=ms1000001052076493, createdTime=Fri Dec 02 17:42:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=538256, encodeId=7ff253825675, content=今早查with editor了,还有一个共同作者没有confirm copyright。分享下经验,大家投这个杂志不用先催着合作者confirm<span class="quote">around 2017-06-18 发表::<br>请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?</span>, beContent=around 2017-06-18 发表:: 请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Tue Jun 20 15:18:00 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207830, encodeId=08f0120e8302c, content=三个月了,还是显示under review,需要发邮件去问一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3475306406, createdName=14879d50m30暂无昵称, createdTime=Fri Apr 01 13:08:47 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214985, encodeId=fac9121498519, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:高血压<br>经验分享:昨天晚上投稿,今早一醒来拒稿了,这个速度我真的会谢,让我转投medicine,感觉都是套路,直接拒绝,栓Q, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Wed Apr 27 10:31:26 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093359, encodeId=05e41093359a6, content=什么样的题目能让审稿人眼前一亮?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093360, encodeId=5d7310933603d, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2017-06-20 around

    今早查with editor了,还有一个共同作者没有confirm copyright。分享下经验,大家投这个杂志不用先催着合作者confirmaround 2017-06-18 发表::
    请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?

    around 2017-06-18 发表:: 请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2146941, encodeId=0eff2146941f8, content=返修两月后连着三天显示decision in process是咋回事?要被拒了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44cf5506636, createdName=ms2000000177740546, createdTime=Sat Jul 08 08:51:06 CST 2023, time=2023-07-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1067018, encodeId=cc66106e01811, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投稿约一个月后Under review,过两周Minor revision,一周后修回,过十天Under review,一天后Decision in process,再过一天Accept。投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Nov 04 19:37:08 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115182, encodeId=daed2115182bf, content=偏重的研究方向:脉压差;高血压<br>经验分享:停在required review completed好几天是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63bb2396905, createdName=12346673m56暂无昵称, createdTime=Sat Feb 18 00:24:42 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=525657, encodeId=ee9252565ee1, content=一审一个月拒稿,但表示可以修改后重投,7月29号投回去,现在是required reviewers completed 已经三天了,坐等结果!各位大神有过这样的经验没有,急求!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab876092, createdName=dongjun2935, createdTime=Mon Aug 08 16:16:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103971, encodeId=50ce21039e139, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:临床回顾性研究,两天拒稿,良心杂志啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cabd8369335, createdName=ms1000001052076493, createdTime=Fri Dec 02 17:42:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=538256, encodeId=7ff253825675, content=今早查with editor了,还有一个共同作者没有confirm copyright。分享下经验,大家投这个杂志不用先催着合作者confirm<span class="quote">around 2017-06-18 发表::<br>请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?</span>, beContent=around 2017-06-18 发表:: 请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Tue Jun 20 15:18:00 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207830, encodeId=08f0120e8302c, content=三个月了,还是显示under review,需要发邮件去问一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3475306406, createdName=14879d50m30暂无昵称, createdTime=Fri Apr 01 13:08:47 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214985, encodeId=fac9121498519, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:高血压<br>经验分享:昨天晚上投稿,今早一醒来拒稿了,这个速度我真的会谢,让我转投medicine,感觉都是套路,直接拒绝,栓Q, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Wed Apr 27 10:31:26 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093359, encodeId=05e41093359a6, content=什么样的题目能让审稿人眼前一亮?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093360, encodeId=5d7310933603d, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-04-01 14879d50m30暂无昵称

    三个月了,还是显示under review,需要发邮件去问一下吗?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2146941, encodeId=0eff2146941f8, content=返修两月后连着三天显示decision in process是咋回事?要被拒了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44cf5506636, createdName=ms2000000177740546, createdTime=Sat Jul 08 08:51:06 CST 2023, time=2023-07-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1067018, encodeId=cc66106e01811, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投稿约一个月后Under review,过两周Minor revision,一周后修回,过十天Under review,一天后Decision in process,再过一天Accept。投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Nov 04 19:37:08 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115182, encodeId=daed2115182bf, content=偏重的研究方向:脉压差;高血压<br>经验分享:停在required review completed好几天是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63bb2396905, createdName=12346673m56暂无昵称, createdTime=Sat Feb 18 00:24:42 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=525657, encodeId=ee9252565ee1, content=一审一个月拒稿,但表示可以修改后重投,7月29号投回去,现在是required reviewers completed 已经三天了,坐等结果!各位大神有过这样的经验没有,急求!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab876092, createdName=dongjun2935, createdTime=Mon Aug 08 16:16:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103971, encodeId=50ce21039e139, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:临床回顾性研究,两天拒稿,良心杂志啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cabd8369335, createdName=ms1000001052076493, createdTime=Fri Dec 02 17:42:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=538256, encodeId=7ff253825675, content=今早查with editor了,还有一个共同作者没有confirm copyright。分享下经验,大家投这个杂志不用先催着合作者confirm<span class="quote">around 2017-06-18 发表::<br>请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?</span>, beContent=around 2017-06-18 发表:: 请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Tue Jun 20 15:18:00 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207830, encodeId=08f0120e8302c, content=三个月了,还是显示under review,需要发邮件去问一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3475306406, createdName=14879d50m30暂无昵称, createdTime=Fri Apr 01 13:08:47 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214985, encodeId=fac9121498519, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:高血压<br>经验分享:昨天晚上投稿,今早一醒来拒稿了,这个速度我真的会谢,让我转投medicine,感觉都是套路,直接拒绝,栓Q, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Wed Apr 27 10:31:26 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093359, encodeId=05e41093359a6, content=什么样的题目能让审稿人眼前一亮?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093360, encodeId=5d7310933603d, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-04-27 ms6000001781488545

    审稿速度:1.0 | 投稿命中率:5.0
    偏重的研究方向:高血压
    经验分享:昨天晚上投稿,今早一醒来拒稿了,这个速度我真的会谢,让我转投medicine,感觉都是套路,直接拒绝,栓Q

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2146941, encodeId=0eff2146941f8, content=返修两月后连着三天显示decision in process是咋回事?要被拒了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44cf5506636, createdName=ms2000000177740546, createdTime=Sat Jul 08 08:51:06 CST 2023, time=2023-07-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1067018, encodeId=cc66106e01811, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投稿约一个月后Under review,过两周Minor revision,一周后修回,过十天Under review,一天后Decision in process,再过一天Accept。投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Nov 04 19:37:08 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115182, encodeId=daed2115182bf, content=偏重的研究方向:脉压差;高血压<br>经验分享:停在required review completed好几天是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63bb2396905, createdName=12346673m56暂无昵称, createdTime=Sat Feb 18 00:24:42 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=525657, encodeId=ee9252565ee1, content=一审一个月拒稿,但表示可以修改后重投,7月29号投回去,现在是required reviewers completed 已经三天了,坐等结果!各位大神有过这样的经验没有,急求!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab876092, createdName=dongjun2935, createdTime=Mon Aug 08 16:16:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103971, encodeId=50ce21039e139, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:临床回顾性研究,两天拒稿,良心杂志啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cabd8369335, createdName=ms1000001052076493, createdTime=Fri Dec 02 17:42:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=538256, encodeId=7ff253825675, content=今早查with editor了,还有一个共同作者没有confirm copyright。分享下经验,大家投这个杂志不用先催着合作者confirm<span class="quote">around 2017-06-18 发表::<br>请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?</span>, beContent=around 2017-06-18 发表:: 请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Tue Jun 20 15:18:00 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207830, encodeId=08f0120e8302c, content=三个月了,还是显示under review,需要发邮件去问一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3475306406, createdName=14879d50m30暂无昵称, createdTime=Fri Apr 01 13:08:47 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214985, encodeId=fac9121498519, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:高血压<br>经验分享:昨天晚上投稿,今早一醒来拒稿了,这个速度我真的会谢,让我转投medicine,感觉都是套路,直接拒绝,栓Q, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Wed Apr 27 10:31:26 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093359, encodeId=05e41093359a6, content=什么样的题目能让审稿人眼前一亮?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093360, encodeId=5d7310933603d, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-29 MS54455111222

    什么样的题目能让审稿人眼前一亮?

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2146941, encodeId=0eff2146941f8, content=返修两月后连着三天显示decision in process是咋回事?要被拒了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44cf5506636, createdName=ms2000000177740546, createdTime=Sat Jul 08 08:51:06 CST 2023, time=2023-07-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1067018, encodeId=cc66106e01811, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:投稿约一个月后Under review,过两周Minor revision,一周后修回,过十天Under review,一天后Decision in process,再过一天Accept。投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f2d5415396, createdName=ms4000001698136241, createdTime=Thu Nov 04 19:37:08 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115182, encodeId=daed2115182bf, content=偏重的研究方向:脉压差;高血压<br>经验分享:停在required review completed好几天是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63bb2396905, createdName=12346673m56暂无昵称, createdTime=Sat Feb 18 00:24:42 CST 2023, time=2023-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=525657, encodeId=ee9252565ee1, content=一审一个月拒稿,但表示可以修改后重投,7月29号投回去,现在是required reviewers completed 已经三天了,坐等结果!各位大神有过这样的经验没有,急求!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab876092, createdName=dongjun2935, createdTime=Mon Aug 08 16:16:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103971, encodeId=50ce21039e139, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:临床回顾性研究,两天拒稿,良心杂志啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cabd8369335, createdName=ms1000001052076493, createdTime=Fri Dec 02 17:42:17 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=538256, encodeId=7ff253825675, content=今早查with editor了,还有一个共同作者没有confirm copyright。分享下经验,大家投这个杂志不用先催着合作者confirm<span class="quote">around 2017-06-18 发表::<br>请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?</span>, beContent=around 2017-06-18 发表:: 请教前辈,是不是在所有共同作者确认copyright之前杂志不会开始审稿程序?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Tue Jun 20 15:18:00 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207830, encodeId=08f0120e8302c, content=三个月了,还是显示under review,需要发邮件去问一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3475306406, createdName=14879d50m30暂无昵称, createdTime=Fri Apr 01 13:08:47 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214985, encodeId=fac9121498519, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:高血压<br>经验分享:昨天晚上投稿,今早一醒来拒稿了,这个速度我真的会谢,让我转投medicine,感觉都是套路,直接拒绝,栓Q, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Wed Apr 27 10:31:26 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093359, encodeId=05e41093359a6, content=什么样的题目能让审稿人眼前一亮?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093360, encodeId=5d7310933603d, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 桑晒麦拉

    审稿人一般更青睐于什么样的题目?

    1

    展开1条回复
共98条页码: 1/10页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分